• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

More bad news for Contrave


<







Just when you thought you could take that clown nose off BAM! You gotta put that shit back on!

At Takeda, It's Halloween all day errday!


This isn't Takeda Faux Pas but Orexigen. There is no way they can facilitate a new post launch CV study in a timely manner to please the FDA. Sadly Convene had little participation and new protocols are needed to be orchestrated; the split between Takeda and Orexigen are to blame. Again loose lips sinks ships.

Too bad a great drug as well.
 




Similar threads

Replies
2
Views
1K
Takeda
Anonymous
Replies
1
Views
1K
Takeda
anonymous
Replies
4
Views
1K
Takeda
anonymous